Spyre Therapeutics, Inc.

STATE OF WISCONSIN INVESTMENT BOARD SYRE

Report date

3/31/2021

Quarter

2021 Q1

Filed

5/17/2021

Shares

60,300

Value ($000)

478

Weight

0.0%

2019 Q4 - 2021 Q1 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q1	5/17/2021	478	0.0%	60,300	3/31/2021
2020 Q4	2/3/2021	475	0.0%	60,300	12/31/2020
2020 Q3	11/16/2020	481	0.0%	67,800	9/30/2020
2019 Q4	2/14/2020	303	0.0%	39,700	12/31/2019